(EMAILWIRE.COM, August 23, 2017 ) Browse 218 Market Data Tables and 44 Figures spread through 283 Pages and in-depth TOC on "Lateral Flow Assay Market - Global Forecast to 2022"
http://www.marketsandmarkets.com/Market-Reports/lateral-flow-assay-market-167205133.html
Early buyers will receive 10% customization on reports.

“By product, the kits & reagents segment accounted for the largest share of the market in 2016.”

On the basis of product, the kits & reagents segment accounted for the largest share of the global lateral flow assay market. The large share of this segment can be attributed to the increasing application of lateral flow kits & reagents for point-of-care testing, growing burden of chronic diseases, and increasing use of lateral flow kits in home care.

Download PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=167205133

“By application, the clinical/point-of-care testing segment held the largest market share in 2016.”

Based on application, the clinical/point-of-care testing segment accounted for the largest share of the LFA market. The rise in population levels & prevalence of chronic diseases, growing pressure to reduce healthcare costs, and increasing demand for patient-centric care are the major factors driving the growth of the clinical/POC testing market.

“North America dominated the market in 2016.”

North America accounted for the largest share of the lateral flow assay market in 2016, followed by Europe and Asia-Pacific. The presence of a highly developed healthcare system, rising geriatric population, increasing incidence of chronic diseases, quick adoption of new innovative products, and a large number of lateral flow assay kits manufacturing companies in this region are the major factors responsible for the largest share of North America in the lateral flow assay market.

Request Sample Pages@ http://www.marketsandmarkets.com/requestsample.asp?id=167205133

The prominent players in the global lateral flow assay market are Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Siemens AG (Germany), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Johnson & Johnson (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), and PerkinElmer, Inc. (U.S.).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.